Long-term  ||| S:0 E:10 ||| JJ
ex vivo  ||| S:10 E:18 ||| NN
and  ||| S:18 E:22 ||| CC
in vivo  ||| S:22 E:30 ||| CD
monitoring  ||| S:30 E:41 ||| NN
of  ||| S:41 E:44 ||| IN
tumor  ||| S:44 E:50 ||| NN
progression  ||| S:50 E:62 ||| NN
by  ||| S:62 E:65 ||| IN
using  ||| S:65 E:71 ||| VBG
dual  ||| S:71 E:76 ||| JJ
luciferases  ||| S:76 E:88 ||| NN
We  ||| S:88 E:91 ||| PRP
propose  ||| S:91 E:99 ||| VBP
a  ||| S:99 E:101 ||| DT
new  ||| S:101 E:105 ||| JJ
concept  ||| S:105 E:113 ||| NN
of  ||| S:113 E:116 ||| IN
tumor  ||| S:116 E:122 ||| NN
progression  ||| S:122 E:134 ||| NN
monitoring  ||| S:134 E:145 ||| NN
using  ||| S:145 E:151 ||| VBG
dual  ||| S:151 E:156 ||| JJ
luciferases  ||| S:156 E:168 ||| NN
in  ||| S:168 E:171 ||| IN
living  ||| S:171 E:178 ||| VBG
animals  ||| S:178 E:186 ||| NNS
to  ||| S:186 E:189 ||| TO
reduce  ||| S:189 E:196 ||| VB
stress  ||| S:196 E:203 ||| NN
for  ||| S:203 E:207 ||| IN
small  ||| S:207 E:213 ||| JJ
animals  ||| S:213 E:221 ||| NNS
and  ||| S:221 E:225 ||| CC
the  ||| S:225 E:229 ||| DT
cost  ||| S:229 E:234 ||| NN
of  ||| S:234 E:237 ||| IN
luciferin ||| S:237 E:246 ||| NN
.  ||| S:246 E:248 ||| .
The  ||| S:248 E:252 ||| DT
secreted  ||| S:252 E:261 ||| FW
Cypridina  ||| S:261 E:271 ||| FW
luciferase  ||| S:271 E:282 ||| FW
( ||| S:282 E:283 ||| -LRB-
CLuc ||| S:283 E:287 ||| NNP
)  ||| S:287 E:289 ||| -RRB-
was  ||| S:289 E:293 ||| VBD
used  ||| S:293 E:298 ||| VBN
as  ||| S:298 E:301 ||| IN
an  ||| S:301 E:304 ||| DT
ex vivo  ||| S:304 E:312 ||| JJ
indicator  ||| S:312 E:322 ||| NN
to  ||| S:322 E:325 ||| TO
continuously  ||| S:325 E:338 ||| RB
monitor  ||| S:338 E:346 ||| VB
tumor  ||| S:346 E:352 ||| NN
progression ||| S:352 E:363 ||| NN
.  ||| S:363 E:365 ||| .
On  ||| S:365 E:368 ||| IN
the  ||| S:368 E:372 ||| DT
other  ||| S:372 E:378 ||| JJ
hand ||| S:378 E:382 ||| NN
,  ||| S:382 E:384 ||| ,
the  ||| S:384 E:388 ||| DT
non-secreted  ||| S:388 E:401 ||| JJ
firefly  ||| S:401 E:409 ||| JJ
luciferase  ||| S:409 E:420 ||| NN
was  ||| S:420 E:424 ||| VBD
used  ||| S:424 E:429 ||| VBN
as  ||| S:429 E:432 ||| IN
an  ||| S:432 E:435 ||| DT
in vivo  ||| S:435 E:443 ||| JJ
indicator  ||| S:443 E:453 ||| NN
to  ||| S:453 E:456 ||| TO
analyze  ||| S:456 E:464 ||| VB
the  ||| S:464 E:468 ||| DT
spatial  ||| S:468 E:476 ||| JJ
distribution  ||| S:476 E:489 ||| NN
of  ||| S:489 E:492 ||| IN
the  ||| S:492 E:496 ||| DT
tumor  ||| S:496 E:502 ||| NN
at  ||| S:502 E:505 ||| IN
suitable  ||| S:505 E:514 ||| JJ
time  ||| S:514 E:519 ||| NN
points  ||| S:519 E:526 ||| NNS
indicated  ||| S:526 E:536 ||| VBD
by  ||| S:536 E:539 ||| IN
CLuc ||| S:539 E:543 ||| JJ
.  ||| S:543 E:545 ||| .
Thus ||| S:545 E:549 ||| RB
,  ||| S:549 E:551 ||| ,
the  ||| S:551 E:555 ||| DT
new  ||| S:555 E:559 ||| JJ
monitoring  ||| S:559 E:570 ||| NN
systems  ||| S:570 E:578 ||| NNS
that  ||| S:578 E:583 ||| WDT
use  ||| S:583 E:587 ||| VBP
dual  ||| S:587 E:592 ||| JJ
luciferases  ||| S:592 E:604 ||| NNS
are  ||| S:604 E:608 ||| VBP
available ||| S:608 E:617 ||| JJ
,  ||| S:617 E:619 ||| ,
allowing  ||| S:619 E:628 ||| VBG
long-term  ||| S:628 E:638 ||| JJ
bioluminescence  ||| S:638 E:654 ||| JJ
imaging  ||| S:654 E:662 ||| NN
under  ||| S:662 E:668 ||| IN
minimal  ||| S:668 E:676 ||| JJ
stress  ||| S:676 E:683 ||| NN
for  ||| S:683 E:687 ||| IN
the  ||| S:687 E:691 ||| DT
experimental  ||| S:691 E:704 ||| JJ
animals ||| S:704 E:711 ||| NNS
.  ||| S:711 E:713 ||| .
